Mammary Tumorigenesis and Malignant Progression

Mammary Tumorigenesis and Malignant Progression

Author: Robert B. Dickson

Publisher: Springer

Published: 1994-07-31

Total Pages: 384

ISBN-13:

DOWNLOAD EBOOK

The current volume represents the fourth over a period of five years in our series on Advances in the Cellular and Molecular Biology of Breast Cancer. The first three volumes were entitled Breast Cancer: Cellular and Molecular Biology, Regulatory Mechanisms in Breast Cancer, and Genes, Oncogenes, and Hormones, respectively. Throughout this series, we have tried to take a broad look at cutting-edge topics in basic science research into breast cancer. This attempt has resulted in a wide range of subject material, including rodent and human model systems, oncogenes, suppressor genes, growth factors, hormones, tumor-host interactions, and determinants of metastases. Since our last volume, research in breast cancer has continued to proceed at an explosive rate. We hope the current volume will provide the reader with some of the excitement felt by the editors and authors as we begin to understand this all-too-common disease. The first section of this book is devoted to the basic processes of proli feration, differentiation, and malignant progression of breast cancer. T.l. Anderson and W.R. Miller lead off with a detailed description of controls on proliferation in the normal human breast and in breast cancer. This chapter strongly emphasizes pathological aspects. The second chapter, by M.R. Stampfer and P. Yaswen, presents a corresponding viewpoint through a presentation of experiments with human mammary epithelial cells in culture. The second section of the book emphasizes the genetic basis for breast cancer onset and malignant progression. Chapter 3, by M.-C. King and S.


CD44 and Hyaluronan in the Regulation of Mammary Gland Development and Breast Cancer Progression

CD44 and Hyaluronan in the Regulation of Mammary Gland Development and Breast Cancer Progression

Author: Jeanne Marguerite VanGils Louderbough

Publisher:

Published: 2011

Total Pages: 300

ISBN-13:

DOWNLOAD EBOOK

Metastasis is the leading cause of death in patients with cancer, and the extracellular matrix is critical to cancer dissemination. The adhesion receptor, CD44, mediates cellular communication with the extracellular matrix by binding to the glycosaminoglycan, hyaluronan (HA). CD44 and HA play critical roles in cancer progression and development. HA is deposited in extracellular and pericellular matrices where it directs intracellular signaling through interactions with cell-surface CD44. CD44-HA interactions, in turn, direct signaling that is relevant to cancer progression. Importantly, these molecules can both promote and inhibit the oncogenic cascade, although the mechanism by which they promote dual and contrasting functions is unknown. Here we show that HA can both activate and suppress EGFR, a critical regulator of oncogenic signaling, in a context-dependent fashion. Using a 3D collagen system in which HA is either polymerized in collagen matrix or provided soluble in the media (sHA) we report that collagen-embedded HA (eHA) inhibits EGFR activation, filopodia formation, and cell spreading on a collagen matrix. Additionally, we show that CD44 is subject to cell-type changes during cancer progression. We have found that CD44 is expressed in the myoepithelium of the developing mammary gland and regulates the normal function of this cell type. The myoepithelial function of CD44 is also relevant to its role in cancer progression as CD44 is expressed in the basal cells of early-stage breast and prostate cancer but undergoes a basal to luminal epithelial switch with increasing tumorigenicity and is strongly expressed by tumor epithelium. These findings demonstrate a novel role for eHA as a protective molecule when encountered in the collagen matrix during cancer progression and highlight the importance of understanding cell-type specific contributions during cancer progression. Taken together, the findings reported in this dissertation point to a mechanism by which CD44 and HA can function in tumor suppression and promotion, depending on cell-type specific expression and modulation of the extracellular matrix.


Targeting Cell Adhesion Proteins During Breast Cancer Progression

Targeting Cell Adhesion Proteins During Breast Cancer Progression

Author: Tung Bui

Publisher:

Published: 2019

Total Pages:

ISBN-13:

DOWNLOAD EBOOK

"Breast cancer progression involves well-defined pathological and clinical stages starting with epithelial hyperproliferation, subsequent evolution into in situ and invasive carcinomas, and finally distal metastases. Although tumor initiation and progression are predominantly driven by acquired genetic alterations, recent data also implicate a supportive role for microenvironmental changes as well. Breast cancer is not a single disease entity but a highly heterogeneous group comprising of several distinct subtypes. Given the complexity of breast cancer, genetically engineered mouse models (GEMMs) have been instrumental in our understanding of malignant transformation. Mammary ducts are comprised of highly organized epithelial cells ensuring the maintenance of tissue homeostasis and tissue architectural integrity via two key classes of cell adhesion: cell-to-cell, and cell-to-extracellular matrix (ECM). Progressive disruption of both types of cell adhesion cooperates with oncogenic activation or tumor suppressor loss to drive malignant transformation. Utilizing GEMMs that faithfully recapitulate human disease, we have highlighted complex and highly context-dependent roles of two classes of cell adhesion proteins: [beta]-catenin (for cell-cell adhesion) and integrins (for cell-ECM adhesion). In the second chapter of the thesis, I show that deletion of [beta]-catenin in a GEMM of basal ErbB2-positive breast cancer reveals complex roles of this protein, due to its functional duality as a structural and a signaling molecule. We show that [beta]-catenin is required for proper adherens junction formation and that consequently, [beta]-catenin haploinsufficiency promotes aggressive tumor formation and metastasis. Defective adherens junctions permit the remaining pool of [beta]-catenin to engage predominantly in its transcriptional activity and promote dedifferentiation and epithelial-to-mesenchymal transition. This haploinsufficient phenotype is unique to a basal ErbB2-positive model with a pre-existing aberrant activation of [beta]-catenin signaling, but not in a model of luminal ErbB2-positive cancer lacking such activity. Taken together, our data argue that the balance of junctional and nuclear [beta]-catenin activity has a profound impact on tumorigenesis in a subtype-dependent manner. In the third chapter of the thesis, I provide genetic evidence to support a functional redundancy between two integrin subunits, [beta]1 and [beta]3, in ErbB2-driven breast cancer. In the absence of [beta]1 integrin, [beta]3 integrin is upregulated to promote tumor initiation, tumor growth and lung metastasis. Mammary-specific disruption both [beta]1 and [beta]3 subunits results in a dramatic delay in ErbB2 tumor progression that is further correlated with a reduction in PI3K/Akt/mTORC1 signaling activity. Mechanistically, [beta]1/[beta]3 integrin receptors engage stiff ECM to recruit insulin receptor INR to the plasma membrane and therefore prevent its lysosomal degradation. Overall, this study emphasizes an important functional crosstalk between integrins and RTK in transducing mechanical cues from tumor microenvironment (TME) to promote breast cancer progression. Finally, in the fourth chapter, I demonstrate a critical role for [beta]1 integrin receptors in a GEMM of luminal B breast cancer. I identify a critical role for [beta]1 integrin receptors in overcoming initial tumor suppressive barriers and thereby permitting efficient transition between pathological stages to give rise to metastatic breast malignancy. However, a small fraction of tumors circumvents the loss of [beta]1 integrin by engaging distinct evolution trajectory including numerous genetic aberrations and extensive remodelling of the TME. In particular, TME exhibits features of chronic inflammation, including increases in ECM deposition, angiogenesis, cancer-associated fibroblast and M2 macrophage infiltration, and pro-inflammatory cytokine production. The mechanisms by which deletion of [beta]1 integrin elicits such inadvertent adaptions remain to be elucidated. " --


Signal Transduction in Cancer

Signal Transduction in Cancer

Author: David A. Frank

Publisher: Springer Science & Business Media

Published: 2002-12-31

Total Pages: 358

ISBN-13: 1402073402

DOWNLOAD EBOOK

One of the most exciting areas of cancer research now is the development of agents which can target signal transduction pathways that are activated inappropriately in malignant cells. The understanding of the molecular abnormalities which distinguish malignant cells from their normal counterparts has grown tremendously. This volume summarizes the current research on the role that signal transduction pathways play in the pathogenesis of cancer and how this knowledge may be used to develop the next generation of more effective and less toxic anticancer agents. Series Editor comments: "The biologic behavior of both normal and cancer cells is determined by critical signal transduction pathways. This text provides a comprehensive review of the field. Leading investigators discuss key molecules that may prove to be important diagnostic and/or therapeutic targets."


Novel Functions for Reelin Signaling in Mammary Gland Development and Breast Cancer Progression

Novel Functions for Reelin Signaling in Mammary Gland Development and Breast Cancer Progression

Author: Elvira R. Khialeeva

Publisher:

Published: 2016

Total Pages: 125

ISBN-13:

DOWNLOAD EBOOK

The reelin signaling pathway is a critical regulator of cell migration and positioning throughout the central nervous system. Recent studies identified non-neuronal functions for reelin, and reported alterations in reelin expression in cancers. It is not known whether the reelin signaling pathway plays a role in the development of the mammary gland or in progression of breast cancer. Using mice with mutations in reelin and Disabled-1 (Dab1), the intracellular adaptor protein activated in response to the reelin signal, we showed that the reelin signaling pathway is required for correct ductal patterning during mammary gland morphogenesis. Reelin and Dab1 are expressed in the developing and the mature mammary duct in a complementary pattern. Mutations in reelin or Dab1 resulted in delayed ductal elongation and disorganized mammary epithelium in mice. Mammary epithelial cells exhibited decreased migration in response to exogenous reelin in a Dab1-dependent manner in vitro. Using a syngeneic mouse mammary tumor transplantation model, we examined the effect of host-derived reelin on breast cancer progression. We found that transplanted tumors grew and metastasized more slowly in reelin-deficient mice. Tumors grown in reelin-deficient animals had fewer blood vessels and increased macrophage infiltration. Loss of host-derived reelin altered the balance of M1- and M2-associated macrophage markers in primary tumors, suggesting that reelin may influence the polarization of tumor-associated macrophages. These results indicated an important function for the reelin protein in progression of breast cancer. Furthermore, we found that several alternatively spliced variants of Dab1 exist in the developing and the mature mammary gland. In addition, we showed that alternative splicing of Dab1 is spatially and temporally regulated during puberty, pregnancy, and lactation. Taken together, our findings suggest that the reelin signaling pathway is an essential regulator of mammary gland development and has critical functions in progression of breast cancer.


3D Cell Culture

3D Cell Culture

Author: Zuzana Koledova

Publisher: Humana Press

Published: 2017-06-21

Total Pages: 452

ISBN-13: 9781493970193

DOWNLOAD EBOOK

This book provides an overview of established 3D cell culture assays from leaders in the field. Their contributions cover a wide spectrum of techniques and approaches for 3D cell culture, from organoid cultures through organotypic models to microfluidic approaches and emerging 3D bioprinting techniques, which are used in developmental, stem cell, cancer, and pharmacological studies, among many others. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Comprehensive and cutting-edge, 3D Cell Culture: Methods and Protocols aims to inspire researchers to develop novel 3D cell culture techniques according to their specific scientific needs and interests, leading to a new generation of physiologically relevant and realistic 3D cell cultures. Chapter 15 of this book is available open access under a CC BY 4.0 license.


Biology of the Mammary Gland

Biology of the Mammary Gland

Author: John A. Mol

Publisher: Springer Science & Business Media

Published: 2006-04-11

Total Pages: 309

ISBN-13: 0306468328

DOWNLOAD EBOOK

Proceedings of the European Cooperation in the Field of Scientific and Technical Research (COST 825) Symposium on Mammary Gland Biology, held September 16-18, 1999, in Tours, France. It is difficult to overstate the evolutionary and functional significance of mammary tissue in biology. Substantial progress has been made by researchers in various disciplines, particularly over the last fifteen years, towards realizing the potential of this tissue to yield powerful experimental models for morphogenesis and tissue development; for cellular differentiation; for the biosynthesis and secretion of proteins, lipids, small molecules and inorganic salts; and for the coordination and regulation of these processes. More recently, the possibility of exploiting the secretory epithelial cells of mammary tissue as `cell factories' has become a reality and the recombinant production by lactating animals of an increasing number of proteins, valuable both in the pharmaceutical and `nutraceutical' fields, is in progress or under development. Also in this sphere of agricultural production, genetic as well as nutritional technologies are under investigation and exploitation to optimize milk composition for various end-uses - for instance in food process and manufacture. The possibilities of deriving health benefit from the bioactive properties of some of the minor constituents of milk are emerging to counter the highly-publicized negative health impact of excessive consumption of saturated animal fats. In human nutrition and medicine, the mammary gland is both a source of nutrition to the neonate and a potential health threat to the adult female - breast cancer remains the major single cause of female mortality in most developed countries. This volume provides a unique glimpse into our understanding, at the cutting edge of a variety of disciplines, of this versatile and extraordinary tissue, at the birth of the twenty-first century.